HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
about
Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related LymphomagenesisAdvances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature ReviewSjögren's syndrome: still not fully understood diseaseEpidemiology of Sjögren's Syndrome-from an Oral PerspectiveReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentNetwork-assisted analysis of primary Sjögren's syndrome GWAS data in Han ChineseGenome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis PatientsSialendoscopic management of autoimmune sialadenitis: a review of literature.The Diagnosis and Treatment of Sjögren's Syndrome.Novel aspects of Sjögren's syndrome in 2012.The association between TNF-α, IL-10 gene polymorphisms and primary Sjögren's syndrome: a meta-analysis and systemic review.How does age at onset influence the outcome of autoimmune diseases?Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-AnalysisAn in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome Patients.Comparison of HLA allelic imputation programs.Epstein-Barr virus in systemic autoimmune diseasesFamilial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjögren's syndrome.Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis.The Relationship of HLA-DQ Alleles with Tuberculosis Risk: A Meta-analysis.Update on Pathogenesis of Sjögren's syndrome.Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry.A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.Human leukocyte antigen haplotype phasing by allele-specific enrichment with peptide nucleic acid probes.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.Genetic associations to germinal centre formation in primary Sjogren's syndrome.B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren's Syndrome.The risk of nontuberculous mycobacterial infection in patients with Sjögren's syndrome: a nationwide, population-based cohort study.Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
P2860
Q26778403-1A62A84B-8102-4423-98B4-C7C139B529F2Q26824039-1846F5CF-951D-4AB1-AA3F-0F52D30F0224Q26851943-A28900D9-B16D-4F11-B696-CFF99228F377Q28069816-71B8EB85-0A57-42DE-AAFD-1DAA87CB2FB5Q30234992-DB62D15C-F0B1-476B-AF79-96EB128C7794Q31033001-6B3C8ACE-794E-4776-9784-DC5B61704CD4Q33601647-8BC4DC6A-B866-428B-889B-B2CB96C99A23Q33686217-68004BDD-52C2-4395-A1C9-02D188EE8DE1Q33777026-F2197601-D7CA-41FC-9B81-D84C9B3AD077Q33800932-32B6B1F9-7A53-41AD-8F22-143F13187C19Q34650103-7A1E2C9C-7170-418E-AF2D-2ED312F7C160Q34749259-13BC5769-B1F7-44DC-92AC-CC84ACD87DAEQ35614906-BEFAC594-3CA3-4D29-BA6E-AA82BC26E4B5Q35936621-8E89603C-5B27-4FDC-88F0-C440EFE4CAC0Q35996410-5CDFA7A1-3A56-4171-92A2-696A42BCD872Q36282969-4F009C5D-1022-49E4-A9EB-E1892C3C46D6Q37154847-BEB5F6D5-22E0-4C8D-AAB6-6335F2BB8473Q37279307-08E94816-3172-44EE-B446-6565CC4ABC5FQ37691215-3F4E41A9-BB1B-43C8-A889-614FDC4D1769Q38197285-13710D07-7D74-474A-8D2D-5ADCAC071466Q38436048-A6780541-1A25-4272-A80F-7522560F3CD3Q38501494-86653F0C-9AE9-4A3A-A1C1-DD86F1995113Q38559605-B93A809D-8861-460C-BBA3-06E50EF696F7Q38793657-AA996F33-C40D-490B-B7F1-BDBAAA56A4A3Q39026679-6279DFD9-2C52-45E3-9671-2387301056F4Q39356677-7329E083-17F4-472A-A2D3-BE8771A9558FQ40437480-D07EB8FB-AB94-48FF-90D6-29995A68349FQ40607323-DB6F9D56-1C04-4C38-B4BB-60430A154856Q41734803-D657E861-C2A7-499B-ABA2-2EB7C7908A96Q42184997-17240426-13C2-42BD-8272-9951E7AE4B9DQ43676169-D33BFF2D-6D33-4682-BC3D-E9071F95E39AQ44534952-DD9AB68D-8637-4E53-B135-C6A279152842Q47161206-6CD1B173-BF11-4BA0-A245-6B510B31FFE6Q47780867-5A5E5FE8-2A7F-4410-8DB6-3FFC54FD33EDQ51075376-155DAAC8-F8DC-4650-B970-7B1DD37A4171
P2860
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@ast
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@en
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@nl
type
label
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@ast
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@en
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@nl
prefLabel
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@ast
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@en
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@nl
P1433
P1476
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies.
@en
P2093
Paola Cruz-Tapias
Shannon Maier-Moore
P304
P356
10.1016/J.AUTREV.2011.10.002
P577
2011-10-07T00:00:00Z